All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Biolinerx Ltd., of Jerusalem, priced an underwritten public offering of 8.4 million American depositary shares (ADS), each representing 10 ordinary shares, at $2.50 per ADS, seeking to raise $21 million.
